Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Summary

This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.

Conditions

• Colorectal Cancer
• Colon Cancer
• Rectal Cancer

Interventions

PROCEDURE

Single-incision Laparoscopic Surgery

In this group，the surgery is performed through a single incision. The surgeon will adjust surgical position to expose the operative field with the help of gravity. Besides，hand over hand cross and parallel techniques are needed to achieve the SILS. All the other operative procedures are the same as conventional laparoscopic surgery.

PROCEDURE

Conventional Laparoscopic Surgery

In this group，the surgery is performed through 3-5 ports according to the surgeons habits and specific conditions.

Sponsors & Collaborators

• Dongfang Hospital Affiliated to Tongji University

  collaborator OTHER

• Fudan University

  collaborator OTHER

• Changhai Hospital

  collaborator OTHER

• Shengjing Hospital

  collaborator OTHER

• RenJi Hospital

  collaborator OTHER

• Liaoning Cancer Hospital & Institute

  collaborator OTHER

• Zhejiang Provincial People's Hospital

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• The General Hospital of Western Theater Command

  collaborator OTHER

• Shanghai Jiao Tong University School of Medicine

  collaborator OTHER

• Ruijin Hospital

  lead OTHER

Principal Investigators

• Ren Zhao, MD, PHD · Ruijin Hospitlal , Shanghai Jiaotong University School of Medicine

• Chun Song, MD · Dongfang Hospital Affiliated to Tongji University

• Ye Xu, MD · Shanghai Cancer Center

• Liqiang Hao, MD · Changhai Hospital

• Hong Zhang, MD · Shengjing Hospital

• Hong Zhou, MD · RenJi Hospital

• Qingtong Zhang, MD · Liaoning Cancer Hospital & Institute

• Shiliang Tu, MD · Zhejiang Provincial People's Hospital

• Xiaoqiao Zhang, MD · Shandong Provincial Hospital

• Lin Zhang, MD · The General Hospital of Western Theater Command

• Feng Gao, MD · The 940th Hospital of Joint Logistic Support Force of Chinese of PLA

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-04-08

Primary Completion

2024-04-30

Completion

2029-04-30

Countries

• China

Study Locations